Chiome Bioscience Inc. (TYO:4583)
Japan
· Delayed Price · Currency is JPY 134.00
+1.00 (0.75%)
May 2, 2025, 3:30 PM JST
Chiome Bioscience Revenue
In the year 2024, Chiome Bioscience had annual revenue of 780.81M JPY with 14.41% growth. Chiome Bioscience had revenue of 358.18M in the quarter ending December 31, 2024, with 126.06% growth.
Revenue
780.81M
Revenue Growth
+14.41%
P/S Ratio
11.63
Revenue / Employee
14.73M
Employees
53
Market Cap
9.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 780.81M | 98.35M | 14.41% |
| Dec 31, 2023 | 682.46M | 51.65M | 8.19% |
| Dec 31, 2022 | 630.82M | -82.12M | -11.52% |
| Dec 31, 2021 | 712.93M | 232.08M | 48.26% |
| Dec 31, 2020 | 480.85M | 33.28M | 7.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Mar 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |